Trial Profile
An acute and continuation phase study of the comparative efficacy of venlafaxine ER (Effexor XR) and fluoxetine (Prozac) in achieving and sustaining remission (wellness) in patients with recurrent unipolar major depression; followed by a long term randomized, placebo-controlled maintenance treatment study in patients treated initially with venlafaxine ER
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2015
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary) ; Fluoxetine
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms PREVENT
- 01 Sep 2015 Results of post hoc analysis presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
- 18 Aug 2009 Actual initiation date (1 Aug 2000) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Actual end date (1 Oct 2005) added as reported by ClinicalTrials.gov.